CN Stock MarketDetailed Quotes

600276 Jiangsu Hengrui Pharmaceuticals

Watchlist
  • 43.05
  • +0.55+1.29%
Trading Aug 15 11:21 CST
274.62BMarket Cap61.94P/E (TTM)

Jiangsu Hengrui Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Jiangsu Hengrui Pharmaceuticals Earnings Date

Currency: CNY

Period

Q2 FY2024 Estimates

Aug 22, 2024

Revenue(YoY)

6.65B

+17.12%
EPS(YoY)

0.33

+92.59%
Analyst Rating

Strong Buy

Aug 14, 2024

Jiangsu Hengrui Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 4 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: CNY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.780B--
Aug 22, 20242024/Q2-- / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--
Oct 26, 20232023/Q35.845B / 6.196B--
DatePeriodRevenue/EstimateEarnings Call
--2024/Q3-- / 6.780B--
Aug 22, 20242024/Q2-- / 6.648B--
Apr 18, 20242024/Q15.998B / 6.071B--
--2023/Q45.806B / 6.199B--
Oct 26, 20232023/Q35.845B / 6.196B--

Unlock Free Earnings Estimates

Jiangsu Hengrui Pharmaceuticals Earnings Reports

  • Summary of Hengrui Pharmaceutical's 2023 Annual Report

    Apr 17 12:00 ET

  • Hengrui Pharmaceutical 2023 Annual Report

    Apr 17 12:00 ET

  • Hengrui Pharmaceutical Report for the First Quarter of 2024

    Apr 17 12:00 ET

  • Hengrui Pharmaceutical\'s report for the third quarter of 2023

    Oct 25, 2023 12:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 14, 2024

    Strong Buy

    • Strong Buy

      87.88%

    • Buy

      9.09%

    • Hold

      3.03%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    CN
    Overall
    Symbol
    Latest Price
    % Chg